Still feeling hungry on Wegovy 0.25mg — is that normal?

The biggest myth: if you're still hungry, Wegovy isn't working

The most common misconception about the 0.25mg dose is that lingering hunger is a sign the medicine has failed. It isn't. Wegovy (semaglutide) is a GLP-1 receptor agonist that slows gastric emptying and signals fullness to the brain, but those effects build with dose. At 0.25mg, the primary goal is tolerability: your gut is being introduced to a new mechanism, and the priority is minimising nausea and other gastrointestinal effects rather than producing strong appetite suppression. The NHS semaglutide medicine guide describes this escalation approach clearly.

Think of it less like a switch and more like a dial. The dial is barely turned at 0.25mg. For many people, real appetite change starts to arrive around 0.5mg or 1.0mg, and if you want to understand what being still hungry on Wegovy at the 0.5mg dose typically looks like, our dedicated guide walks through what to expect at that stage. Some people do notice a modest effect from day one, individual responses vary, and both patterns are legitimate.

If you're finding the starter phase difficult, you're not alone. A question our prescribers hear regularly is whether it's worth pushing through a dose that seems inert. The answer is yes: the tolerability groundwork at 0.25mg is what allows most people to reach the doses where results tend to come. Read more about why hunger persists on Wegovy and what the evidence says about the full titration arc.

What hunger actually feels like on the starter dose, and when it should shift

Hunger on 0.25mg often feels unchanged from pre-treatment. Meals may feel no smaller, snack urges no quieter. That's frustrating when you've started treatment with clear expectations. The shift, for most people, is gradual rather than sudden: fewer thoughts about food between meals, a slightly earlier sense of fullness mid-plate, less urgency around evening snacking. These changes tend to build across the first few months of titration.

If you're several weeks into the starter dose and feel nothing at all, that's worth mentioning to your prescriber at your next review. It doesn't necessarily mean a change of plan, but your clinical team can factor it in when timing your step up. Jumping the schedule yourself isn't advisable: moving up too fast is one of the more predictable ways to trigger the nausea and vomiting that make people abandon treatment early.

If you are on Wegovy but still hungry across doses, our overview explains the range of reasons this happens and what options are available to you, the hunger on Wegovy overview covers what to expect across the full treatment journey.

What you can actually do about hunger right now, at 0.25mg

Since the medicine isn't fully doing the appetite work yet at this dose, the gap has to be filled with strategy. Protein is the most evidence-consistent tool: it slows digestion independently of any GLP-1 effect and blunts the hunger hormone ghrelin. Aim for a protein source at every meal, eggs, Greek yoghurt, fish, legumes, chicken. Fibre does something similar: it adds bulk and delays gastric emptying through a mechanical route. Vegetables, oats, pulses and wholegrains are your allies here.

Meal timing also matters more than people expect. Eating at consistent intervals keeps blood-glucose levels steadier and reduces the sharp hunger spikes that can dominate when GLP-1 effects are still weak. If you tend to hold off eating until you're ravenous, the 0.25mg dose is a poor safety net, hunger management at this stage is still partly behavioural. The guide on eating well on Wegovy goes into practical meal composition in more detail.

Hydration is also genuinely relevant: thirst and mild hunger can be hard to tell apart, particularly in the afternoon. A glass of water before deciding whether you're actually hungry is a low-effort first check. And on the subject of costs and what's included in a private prescription, the treatment overview page sets that out transparently.

When to go back to your prescriber

Persistent hunger alone at 0.25mg is expected. But a few scenarios warrant a proper conversation before your scheduled review. If hunger is accompanied by significant nausea that's making eating difficult, that changes the clinical picture. If you notice no effect whatsoever after four full weeks at 0.25mg and your lifestyle hasn't changed, that's worth flagging. And if you're struggling to eat sufficient protein and calories because side effects are suppressing food intake in an uncomfortable way, your prescriber needs to know.

The NHS England guidance on weight management injections makes clear that dose changes and clinical decisions about continuation are always made by the prescriber, not the patient. That's true whether you're on an NHS pathway or a private service. If you have questions about your specific dose progression, the nume aftercare team is available seven days a week, no appointment needed.

For a broader picture of how Wegovy works as a treatment, including its full licensed dose range, our Wegovy overview is a good next step. And if you're considering starting treatment or are currently on a different dose, check your eligibility with our prescribers.